EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

Kontham Kulangara Varsha, Mitzi Nagarkatti, Prakash Nagarkatti

Advances in Drug and Alcohol Research · 14.07.2022 · 2

DOI: 10.3389/adar.2022.10550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Drug and Alcohol Research, online erschienen am 14.07.2022. Verfasst von Kontham Kulangara Varsha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabinoids and the endocannabinoid system have been well established to play a crucial role in the regulation of the immune response. Also, emerging data from numerous investigations unravel the imperative role of gut microbiota and their metabolites in the maintenance of immune homeostasis and gut barrier integrity. In this review, we concisely report the immunosuppressive mechanisms triggered by cannabinoids, and how they are closely associated with the alterations in the gut microbiome and metabolome following exposure to endogenous or exogenous cannabinoids. We discuss how cannabinoid-mediated induction of microbial secondary bile acids, short chain fatty acids, and indole metabolites, produced in the gut, can suppress inflammation even in distal organs. While clearly, more clinical studies are necessary to establish the cross talk between exo- or endocannabinoid system with the gut microbiome and the immune system, the current evidence opens a new avenue of cannabinoid-gut-microbiota-based therapeutics to regulate immunological disorders.

Schlagwörter

Stichwörter der Autor:innen

cannabinoidsdrug abuseendocannabinoidsinflammationmicrobiota

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.

Förderung

  • NIEHS NIH HHS
  • NIAID NIH HHS
  • NIMH NIH HHS
  • NIGMS NIH HHS
  • NCCIH NIH HHS
  • NIDA NIH HHS
  • Office of Extramural Research, National Institutes of Health

Zitieren

APA

Varsha, K. K., Nagarkatti, M., & Nagarkatti, P. (2022). Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation. Advances in Drug and Alcohol Research, 2. https://doi.org/10.3389/adar.2022.10550

Vancouver

Varsha KK, Nagarkatti M, Nagarkatti P. Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation. Advances in Drug and Alcohol Research. 2022;2. doi:10.3389/adar.2022.10550

BibTeX
@article{Varsha2022,
  author = {Varsha, Kontham Kulangara and Nagarkatti, Mitzi and Nagarkatti, Prakash},
  title = {Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation},
  journal = {Advances in Drug and Alcohol Research},
  year = {2022},
  volume = {2},
  doi = {10.3389/adar.2022.10550}
}
Kostenlos starten →